Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-079712
Filing Date
2025-05-30
Accepted
2025-05-30 16:07:50
Documents
2
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4272
2 EX-24 fate-ex24.htm EX-24 9284
  Complete submission text file 0000950170-25-079712.txt   14979
Mailing Address C/O VERACYTE, INC. 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
EPSTEIN ROBERT S (Reporting) CIK: 0001252004 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 251010925

Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)